Why is Par Drugs & Che. falling/rising?

As of 22-Jul, Par Drugs & Chemicals Ltd is experiencing a price increase, currently at 117.08, reflecting a rise of 5.57 or 5.0%. The stock has shown strong performance in the short term, with a 22.80% increase over the past week and a 21.54% increase over the past month, significantly outperforming the Sensex, which has declined by 0.54% and 0.21% respectively during those periods. Today's price summary indicates that the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. The company benefits from a low debt-to-equity ratio and a return on equity of 13.8, suggesting an attractive valuation relative to its peers, despite a significant decline of 51.10% over the past year.
In the broader market context, while Par Drugs & Chemicals Ltd has outperformed the sector today, it has consistently underperformed against the benchmark over the last three years, with a notable decline in net sales and operating profit growth. The stock's long-term growth prospects appear poor, as evidenced by a 68.77% drop in profit after tax over the last six months and a 12.0% decline in net sales compared to the previous quarter's average. This underperformance, combined with the negative results reported, suggests that while there may be short-term gains, the overall outlook remains challenging compared to the broader market trends.